biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by roadking08on Oct 02, 2017 7:43pm

186 Views

Post# 26768645

RE:RE:RE:RE:RE:biOasis Appoints Christopher P. Lowe as CFO & Board Advisor

To the champ that gave me one star, presuming your a guy, you sir must most probably short the stock or just dislike money, probably having also issues conneticuting the dots.
Either way bro, give this one also a lonely star, I don't not work paying my sheet with stars, I usually pay cash.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta